SCOHIA PHARMA is a specialty bioventure with great expertise in the field of lifestyle-related diseases such as cardiovascular, metabolic, and renal diseases.
-
Business
2021.11.12
Awarded the 3rd prize of the Boehringer Ingelheim Innovation Prize, 2021
-
Business
2021.11.11
IP6K inhibitor（SCO-006）information has been updated
-
Paper
2021.08.19
Publication of a preclinical study: Inositol hexakisphosphate kinase (IP6K) is crucial in regulating plasma phosphate levels in vivo, and SCO-006-mediated IP6K inhibition is a potential novel treatment strategy against hyperphosphatemia
Page Top